Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of ARD-0403 in male hypogonadism
NCT00562731Phase 3Terminated
- Sponsor
- Ardana
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of testosterone in male hypogonadism, sponsored by Ardana. Primary endpoint: Efficacy. Started Oct 2007; status: terminated.
02
Drugs
testosterone
03
Conditions
male hypogonadism
Beyond the preview
Go deeper on NCT00562731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00562731.